Alveolar Soft Part Sarcoma Overview

Save information for later
Sign Up

Learn About Alveolar Soft Part Sarcoma

What is the definition of Alveolar Soft Part Sarcoma?
Alveolar soft part sarcoma (ASPS) is a rare, slow-growing soft tissue sarcoma. Although it has been described in a variety of locations, it most commonly develops on the lower extremities in adults and in the head and neck region of children. ASPS generally presents as a soft, pain-less lump that is often not associated with any additional signs and symptoms. In many cases, the condition is not diagnosed until the affected person develops symptoms of metastasis to other sites such as the lungs, bones, central nervous system and/or liver. The underlying cause of ASPS is poorly understood. Most cases occur sporadically in people with no family history of the condition.
What are the alternative names for Alveolar Soft Part Sarcoma?
  • Alveolar soft part sarcoma
  • ASPS
Who are the top Alveolar Soft Part Sarcoma Local Doctors?
Piotr L. Rutkowski
Elite in Alveolar Soft Part Sarcoma
Piotr L. Rutkowski
Elite in Alveolar Soft Part Sarcoma
Piotr L. Rutkowski
Cracow Branch, 
Krakow, MA, PL 

Piotr Rutkowski practices in Krakow, Poland. Mr. Rutkowski and is rated as an Elite expert by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Melanoma, Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Lymphadenectomy, and Pancreaticoduodenectomy.

Mark A. Dickson
Distinguished in Alveolar Soft Part Sarcoma
Dr. Mark A. Dickson
Hematology Oncology | Hematology | Oncology
Distinguished in Alveolar Soft Part Sarcoma
Dr. Mark A. Dickson
Hematology Oncology | Hematology | Oncology

Memorial Solid Tumor Group

160 E 53rd St, 
New York, NY 
212-639-2000
Languages Spoken:
English
Offers Telehealth

Mark Dickson is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Dickson and is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Undifferentiated Pleomorphic Sarcoma, Fibrosarcoma, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Todd W. Bauer
Distinguished in Alveolar Soft Part Sarcoma
Dr. Todd W. Bauer
Surgical Oncology | General Surgery
Distinguished in Alveolar Soft Part Sarcoma
Dr. Todd W. Bauer
Surgical Oncology | General Surgery

University Of Virginia Physicians Group

1215 Lee St, 
Charlottesville, VA 
434-243-6868
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Todd Bauer is a Surgical Oncologist and a General Surgeon in Charlottesville, Virginia. Dr. Bauer and is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Neuroendocrine Tumor, Hepatectomy, and Pancreaticoduodenectomy. Dr. Bauer is currently accepting new patients.

View All Doctors
What are the latest Alveolar Soft Part Sarcoma Clinical Trials?
A Feasibility Multicenter Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
A Feasibility Multicenter Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Enrollment Status: Recruiting
Publish Date: April 17, 2025
Intervention Type: Drug
Study Phase: Phase 1

Background: A type of drug called monoclonal antibody immune checkpoint inhibitors are often used in cancer treatment. These drugs help the body s immune system fight cancer by blocking proteins that cause cancer cells to grow. One of these drugs (atezolizumab) is approved to treat certain cancers. Researchers want to find out if lower doses of this drug might provide the same benefit with fewer adverse effec...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2 Study of Atezolizumab With Selinexor in Alveolar Soft Part Sarcoma (AXIOM)
A Phase 2 Study of Atezolizumab With Selinexor in Alveolar Soft Part Sarcoma (AXIOM)
Enrollment Status: Recruiting
Publish Date: April 16, 2025
Intervention Type: Procedure, Drug, Biological
Study Phase: Phase 2

Summary: This phase II trial tests whether atezolizumab in combination with selinexor works to shrink tumors in patients with alveolar soft part sarcoma and whether the study drugs are better than the usual approach in treating this type of cancer. The usual approach is defined as care most people get for alveolar soft part sarcoma if they are not part of a clinical study, which includes treatment with rad...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center